Candida dubliniensis is an emerging pathogen capable of causing superficial as well as systemic infections.
INTRODUCTION
Candida species usually reside as commensals at mucosal membranes in healthy individuals and can be detected in approximately 50% of the population in this non-virulent form.
However, under conditions when the host's normal flora is disrupted or the immunity is impaired, Candida species often become pathogenic. Candida infections have become a problem of growing significance. The incidence of infections has increased dramatically over the past a few decades. C. albcians is the most common pathogen in this genus and fourth leading cause of nonsocomial bloodstream infections (4, 21) .
However, several non-albicans Candida species, e.g. C.
glabrata, C. tropicalis and C. parapsilosis, have emerged as causative agents of candidiasis (20) . Another Candida species of growing clinical importance is C. dubliniensis, a novel Identification of C. dubliniensis can be problematic due to its close phenotypic similarity to C. albicans. Both species produces germ tubes, chlamydospores and true hyphae (26) .
Several phenotypic assays have been developed to differentiate
C. dubliniensis from C. albicans, including the capacity to grow at 45°C, formation of chlamydospores on selected media, the ability to assimilate xylose, lactate or α-methyl-D-glucoside and different colony color produced on CHROMagar Candida medium (2, 5, 23, 28) . These assays can serve as rapid methods to screen for potential C. dubliniensis isolates. But none of these assays have proved to be efficient and entirely reliable.
At present, the most accurate means of differentiating between these two closely related species requires the use of molecular biology-based techniques, such as electrophoretic karyotyping, DNA fingerprinting analysis with repetitive sequencecontaining DNA probes, randomly amplified polymorphic DNA analysis, restriction fragment length polymorphism (RFLP), amplified fragment length polymorphism, conventional and real-time PCR analysis, or pulsed-field gel electrophoresis (18, 25) . These methods proved very effective.
Among them, PCR-RFLP analysis is a simple and reliable one.
In this study we developed and evaluated a PCR-RFLP assay to identify and discriminate between C. albicans and C.
dubliniensis.
MATERIALS AND METHODS

Yeast Strains
C. albicans (SC 5314), C. dubliniensis (CBS 7987), C. 
Sequence Analyses and Selection of Restriction Enzymes
A total of 30 sequences of the 28S ribosomal DNA The resulting fragments were separated on 2% agarose gels and visualized under UV light after ethidium bromide staining, with a 100bp DNA ladder for fragment size comparison.
RESULT Sequence Analyses
An extensive analysis of database entries of yeast species tested in this study was performed with respect to calculated fragment lengths of the D1/D2 regions generated by commercially available restriction enzymes. Minor differences in calculated lengths of PCR products were observed. Finally, ApaI and BsiEI were selected to be evaluated in experiment.
Predicted fragment lengths of ApaI and BsiEI-digested PCR products are given in 
PCR Amplification of D1/D2 Regions
As shown in Fig.1 , intended DNA fragments of all reference strains were successfully amplified with primers NL-1 and NL-4. PCR products were found to reach 550-600 bp in length as predicted from sequence analysis. However, most tested species, except C. lusitaniae, were inseparable due to similar PCR amplicon sizes. C. albicans and its closely related C. dubliniensis
RFLP Analyses of Reference Strains
When digested with ApaI, D1/D2 regions of C. albicans and C. dubliniensis strains shared the same restriction pattern, with two bands of almost identical sizes (134bp, 481bp for C. albicans and 134bp, 480bp for C. dubliniensis) (Fig.2) . Nevertheless, amplicons of other yeast strains were undigested by ApaI, which easily distinguished C. albicans and C. dubliniensis from other tested species. Digestion of the D1/D2 region with BsiEI generated distinctive restriction profiles for C. albicans: two fragments of 181bp and 434bp (Fig.3 ). In addition, BsiEI also cut into two fragments the PCR-products of C. glabrata (149bp and 475bp), C.
krusei (59bp and 548bp) and C. lusitaniae (126bp and 433bp). As was seen in Fig.3 , the differences in fragment lengths were sufficient to discriminate C. albicans from C. glabrata, C. krusei and C. lusitaniae. Other tested species were undigested by BsiEI, including C. dubliniensis. Therefore, two separate enzymatic digestions produced species-specific RFLP profiles for C. albicans and C. dubliniensis. dubliniensis, results are not always reliable as was seen in our study (3, 12, 23) . Confirmatory identification of C. dubliniensis always requires the molecular methods.
PCR-RFLP assays have been successfully applied to the identification of Candida species (17, 22, 29) . Compared with other molecular methods, PCR-RFLP analysis is generally easy and rapid to perform. Although more complex RFLP methods have previously been used for the identification of C.
dubliniensis, their use may be limited since they were timeconsuming or the results were difficult to interpret (18) .Thus in this study, simpler but more advantageous PCR-RFLP is preferred due to its increased applicability in clinical laboratories.
Ribosomal regions, such as the internal transcribed spacer (ITS) region and 28S rDNA, exhibit a low intraspecific polymorphism and a high interspecific variability, making them ideal targets for species identification purposes (9) . In this study, we selected the D1/D2 variable region at the 5' end of the 28S rDNA gene as target for PCR amplification.
Sequencing of this region has been demonstrated to be sufficient for accurate identification of most yeast species (11) .
Between C. albicans and C. dubliniensis, there are 13 nucleotide differences in the region D1/D2, sufficiently variable for reliable differentiation. Two enzymes, ApaI and BsiEI, were selected based on the restriction profiles generated Ge, Y.P. et al. C. albicans and its closely related C. dubliniensis by these nucleotide differences. Despite that only a limited number of C. albicans and C. dubliniensis isolates were investigated, those restriction sites for ApaI and BsiEI seemed to be well conserved in these two species.
Several PCR-RFLP assays have been described so far to discriminate between C. albicans and C. dubliniensis (Table 1) The differentiation was achieved by analysis of the PCR products with BsmAI (C. dubliniensis-specific) and NspBIII (C.
albicans-specific) (19) . Three other PCR-RFLP assays also used a similar strategy by targeting a part or whole of the ITS region (1, 6, 14) . All these methods proved effective for accurate identification. In comparison, our study used a slightly different strategy. We first identified a restriction site for ApaI which was specific to both species, instantly separating them from other yeast species. Subsequently BsiEI was found to produce C. albicans specific pattern and C. dubliniensis was identified by absence of the restriction site.
An advantage of the method described here is the stable and easy-to-read RFLP patterns. Unlike previous reports, this method involves only one or two DNA fragments. Besides, it is a simple and rapid method to perform. With the aid of timesaving restriction enzymes, the whole process can be accomplished in less than 6h, requiring no sophisticated equipments except a conventional thermal cycler. Considering that DNA sequencer may not be readily available to most clinical laboratories, this molecular method is applicable for unequivocal identification and differentiation of C. albicans and C. dubliniensis.
